Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6900
+0.0200 (1.20%)
NASDAQ· Last Trade: Jun 4th, 3:55 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors